Insufficient scRNA-seq data for expression of FDX2 at single-cell level.
Insufficient scRNA-seq data for expression of FDX2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 551.51 | 180 / 180 | 1% | 0.01 | 3 / 430 |
intestine | 100% | 560.92 | 965 / 966 | 1% | 0.01 | 3 / 527 |
kidney | 100% | 945.44 | 89 / 89 | 0% | 0.01 | 1 / 901 |
stomach | 100% | 459.45 | 358 / 359 | 0% | 0.00 | 1 / 286 |
adrenal gland | 100% | 812.90 | 258 / 258 | 0% | 0 | 0 / 230 |
bladder | 100% | 665.81 | 21 / 21 | 0% | 0 | 0 / 504 |
liver | 100% | 490.12 | 226 / 226 | 0% | 0 | 0 / 406 |
pancreas | 100% | 361.20 | 328 / 328 | 0% | 0 | 0 / 178 |
prostate | 100% | 766.04 | 245 / 245 | 0% | 0 | 0 / 502 |
spleen | 100% | 551.18 | 241 / 241 | 0% | 0 | 0 / 0 |
thymus | 100% | 998.78 | 653 / 653 | 0% | 0 | 0 / 605 |
uterus | 100% | 573.92 | 170 / 170 | 0% | 0 | 0 / 459 |
brain | 100% | 1434.55 | 2641 / 2642 | 0% | 0 | 0 / 705 |
breast | 100% | 543.87 | 458 / 459 | 0% | 0 | 0 / 1118 |
skin | 100% | 528.63 | 1805 / 1809 | 0% | 0 | 0 / 472 |
esophagus | 100% | 561.93 | 1441 / 1445 | 0% | 0 | 0 / 183 |
adipose | 100% | 505.45 | 1199 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 550.60 | 1329 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 458.12 | 795 / 803 | 0% | 0 | 0 / 0 |
lung | 99% | 505.67 | 572 / 578 | 0% | 0 | 0 / 1155 |
heart | 97% | 457.48 | 839 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 55% | 172.57 | 507 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0022900 | Biological process | electron transport chain |
GO_0016226 | Biological process | iron-sulfur cluster assembly |
GO_0140647 | Biological process | P450-containing electron transport chain |
GO_0044572 | Biological process | [4Fe-4S] cluster assembly |
GO_0044571 | Biological process | [2Fe-2S] cluster assembly |
GO_1990229 | Cellular component | iron-sulfur cluster assembly complex |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0051537 | Molecular function | 2 iron, 2 sulfur cluster binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0009055 | Molecular function | electron transfer activity |
Gene name | FDX2 |
Protein name | Ferredoxin-2, mitochondrial (Adrenodoxin-like protein) (Ferredoxin-1-like protein) Ferredoxin 2 |
Synonyms | FDX1L |
Description | FUNCTION: Electron donor, of the core iron-sulfur cluster (ISC) assembly complex, that acts to reduce the persulfide into sulfide during [2Fe-2S] clusters assembly on the scaffolding protein ISCU . The core iron-sulfur cluster (ISC) assembly complex is involved in the de novo synthesis of a [2Fe-2S] cluster, the first step of the mitochondrial iron-sulfur protein biogenesis. This process is initiated by the cysteine desulfurase complex (NFS1:LYRM4:NDUFAB1) that produces persulfide which is delivered on the scaffold protein ISCU in a FXN-dependent manner. Then this complex is stabilized by FDX2 which provides reducing equivalents to accomplish the [2Fe-2S] cluster assembly. Finally, the [2Fe-2S] cluster is transferred from ISCU to chaperone proteins, including HSCB, HSPA9 and GLRX5 (By similarity). . |
Accessions | A0A0A0MTS8 ENST00000494368.5 A0A9L9PXQ6 ENST00000492239.5 Q6P4F2 ENST00000393708.3 [Q6P4F2-1] ENST00000706663.1 |